Shares of iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report) shot up 2.1% during trading on Wednesday. The stock traded as high as $33.97 and last traded at $33.97. Approximately 2,588 shares traded hands during trading, an increase of 17% from the average daily volume of 2,221 shares. The stock had previously closed at $33.26.
iShares Neuroscience and Healthcare ETF Price Performance
The firm has a market cap of $6.79 million, a P/E ratio of 15.61 and a beta of 0.80. The firm has a fifty day simple moving average of $34.34 and a 200-day simple moving average of $34.80.
iShares Neuroscience and Healthcare ETF Company Profile
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
